OraSure Technologies ( OSUR ) Reports Q3 Loss, Lags Revenue Estimates
OraSure (OSUR) delivered earnings and revenue surprises of +18.75% and -7.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
OraSure ( OSUR ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Nov. 5, 2025 at 5 p.m. ETPresident and Chief Executive Officer - Carrie Eglinton MannerContinue reading ...
InfuSystems Holdings, Inc. ( INFU ) Tops Q3 Earnings Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +37.50% and -1.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
BETHLEHEM, Pa., Oct. 29, 2025 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( NASDAQ: OSUR ) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025.
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors - OraSure Technologies ( NASDAQ:OSUR )
Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective OraSure Board Has Added Three New Independent Directors in the Past Three Years Mara Aspinall to Step Down from the Board.
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective OraSure Board Has Added Three New Independent Directors in the Past Three Years Mara Aspinall to Step Down from the Board.
Tilray Brands, Inc. ( TLRY ) Reports Break-Even Earnings for Q1
Tilray Brands (TLRY) delivered earnings and revenue surprises of +100.00% and +1.29%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
OraSure ( OSUR ) Q2 Revenue Falls 43%
OraSure Technologies ( NASDAQ:OSUR ) , a diagnostics and sample collection device company, released its second quarter 2025 results on August 5, 2025. The earnings showed that GAAP revenue was $31.2 million, slightly above the $30.36 million GAAP Wall Street estimate.
OraSure Technologies ( OSUR ) Reports Q2 Loss, Beats Revenue Estimates
OraSure (OSUR) delivered earnings and revenue surprises of -26.67% and +2.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OraSure Appoints Anne Messing as Chief Commercial Officer
BETHLEHEM, Pa., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( "OTI" ) ( NASDAQ: OSUR ) , a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as Chief Commercial Officer.
OraSure Appoints Anne Messing as Chief Commercial Officer - OraSure Technologies ( NASDAQ:OSUR )
BETHLEHEM, Pa., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( "OTI" ) OSUR, a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as Chief Commercial Officer.
OraSure Launches Novel Blood Collection Device for Proteomic Research
The device has the potential to transform proteomic discovery through extended protein stabilization and a simplified workflow for research The device has the potential to transform proteomic discovery through extended protein stabilization and a simplified workflow for research ...
OraSure Launches Novel Blood Collection Device for Proteomic Research - OraSure Technologies ( NASDAQ:OSUR )
BETHLEHEM, Pa., July 10, 2025 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( "OTI" ) OSUR, a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the launch of its HEMAcollect™●PROTEIN product to meet the evolving needs of proteomic researchers.
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer ( DTC ) Celiac Genetic Testing - OraSure Technologies ( NASDAQ:OSUR )
IRVINE, Calif., May 14, 2025 ( GLOBE NEWSWIRE ) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration ( FDA ) cleared direct-to-consumer ( DTC ) test for celiac disease genetics, today announced a commercial collaboration with OraSure Technologies, ...
OraSure Technologies ( OSUR ) Reports Q1 Loss, Tops Revenue Estimates
OraSure (OSUR) delivered earnings and revenue surprises of -20% and 0.73%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Envista ( NVST ) Beats Q1 Earnings and Revenue Estimates
Envista (NVST) delivered earnings and revenue surprises of 20% and 1.49%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific ( BSX ) Q1 Earnings and Revenues Top Estimates
Boston Scientific (BSX) delivered earnings and revenue surprises of 11.94% and 2.31%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
GE HealthCare ( GEHC ) Surges 10.6%: Is This an Indication of Further Gains?
GE HealthCare (GEHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OraSure Announces $40 Million Stock Repurchase Program
BETHLEHEM, Pa., March 24, 2025 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( the "Company" ) ( NASDAQ: OSUR ) , a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Directors has authorized the repurchase of up to $40 million ...
OraSure Technologies ( OSUR ) Reports Q4 Loss, Tops Revenue Estimates
OraSure (OSUR) delivered earnings and revenue surprises of -200% and 2.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Insulet ( PODD ) Q4 Earnings and Revenues Top Estimates
Insulet (PODD) delivered earnings and revenue surprises of 9.52% and 2.73%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th - OraSure Technologies ( NASDAQ:OSUR )
BETHLEHEM, Pa., Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. OSUR has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET on February 25, 2025.
BellRing Brands ( BRBR ) Beats Q1 Earnings and Revenue Estimates
BellRing Brands (BRBR) delivered earnings and revenue surprises of 23.40% and 1.74%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
OraSure ( OSUR ) Upgraded to Strong Buy: What Does It Mean for the Stock?
OraSure (OSUR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for January 27th
ALNY, HBT, APH, GNTY and OSUR have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2024.
Should Value Investors Buy OraSure Technologies ( OSUR ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bear of the Day: Baxter ( BAX )
The recent earnings trend has been troubling. Can the company turn it around next year?
New Strong Buy Stocks for January 16th
MRCY, BBCP, OSUR, VIK and IFS have been added to the Zacks Rank #1 (Strong Buy) List on January 16, 2025.
Are Investors Undervaluing OraSure Technologies ( OSUR ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
BETHLEHEM, Pa., Jan. 07, 2025 ( GLOBE NEWSWIRE ) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. ( NASDAQ: OSUR ) , please note that the first sentence of the release ( read "OraQuick® HIV Self-Test that will increase access to HIV testing for ...
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
BETHLEHEM, Pa., Jan. 07, 2025 ( GLOBE NEWSWIRE ) -- OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick® HIV Self-Test.
OSUR Stock Rises Following the Acquisition of Sherlock Biosciences
OraSure announces acquisition of Sherlock Biosciences to strengthen its molecular diagnostics portfolio.
OraSure Technologies Acquires Sherlock Biosciences
BETHLEHEM, Pa., Dec. 19, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( "OTI" ) ( NASDAQ: OSUR ) , a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing ...
OraSure Technologies Acquires Sherlock Biosciences - OraSure Technologies ( NASDAQ:OSUR )
BETHLEHEM, Pa., Dec. 19, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( "OTI" ) OSUR, a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation ...
Should Value Investors Buy biote Corp. ( BTMD ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test - OraSure Technologies ( NASDAQ:OSUR )
BETHLEHEM, Pa., Dec. 02, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. OSUR, a leader in point-of-care and home diagnostic tests and sample management solutions, today announced that it received an award through the Rapid Response Partnership Vehicle ( RRPV ) for the development of a ...
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
BETHLEHEM, Pa., Dec. 02, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( NASDAQ: OSUR ) , a leader in point-of-care and home diagnostic tests and sample management solutions, today announced that it received an award through the Rapid Response Partnership Vehicle ( RRPV ) for the ...
Is OraSure Technologies ( OSUR ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
OraSure to Participate in Upcoming Investor Conference - OraSure Technologies ( NASDAQ:OSUR )
BETHLEHEM, Pa., Nov. 18, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. OSUR announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment Conference on Wednesday, November 20, with a Q&A session scheduled for 1 p.m. ET
OraSure to Participate in Upcoming Investor Conference
BETHLEHEM, Pa., Nov. 18, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( NASDAQ: OSUR ) announced today that the company is scheduled to participate in the following investor conference: ...
Is OraSure Technologies ( OSUR ) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phibro Animal Health Corporation ( PAHC ) Hits Fresh High: Is There Still Room to Run?
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
OraSure Technologies ( OSUR ) Reports Q3 Loss, Tops Revenue Estimates
OraSure (OSUR) delivered earnings and revenue surprises of 75% and 1.97%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology
Westford, USA, Oct. 24, 2024 ( GLOBE NEWSWIRE ) -- Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period ( 2024-2031 ) .
At-home Testing Kits Market to be Worth USD 12.3 billion by 2034, Growing a CAGR 5.9% - Exclusive Report by Transparency Market Research, Inc.
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 09, 2024 ( GLOBE NEWSWIRE ) -- The global at-home testing kits market ( 재택 테스트 키트 시장 ) is estimated to ascend at a CAGR of 5.9% from 2024 to 2034.
Drug Screening Market to Reach Market Valuation of USD 35.18 Billion by 2031 | SkyQuest Technology
Westford, USA, Sept. 27, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Drug Screening Market will reach a value of USD 35.18 Billion by 2031, with a CAGR of 16.5% during the forecast period ( 2024-2031 ) .
Smart Money Move: John Kenny Grabs $100K Worth Of OraSure Technologies Stock - OraSure Technologies ( NASDAQ:OSUR )
Disclosed in the latest SEC filing, a significant insider purchase on September 10, involves John Kenny, Board Member at OraSure Technologies OSUR. What Happened: In a recent Form 4 filing with the U.S.
OraSure Technologies Elects Jack Kenny to the Board of Directors - OraSure Technologies ( NASDAQ:OSUR )
BETHLEHEM, Pa., Sept. 09, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. OSUR, a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack Kenny to its Board of Directors, effective September 9, 2024.
OraSure Technologies Elects Jack Kenny to the Board of Directors
BETHLEHEM, Pa., Sept. 09, 2024 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( NASDAQ: OSUR ) , a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack Kenny to its Board of Directors, effective September 9, 2024.
OraSure Technologies ( OSUR ) Tops Q2 Earnings and Revenue Estimates
OraSure (OSUR) delivered earnings and revenue surprises of 133.33% and 1.86%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
